349695 <common-name>(4e)-5-(3,4-dimethoxyphenyl)-4-[hydroxy-(3-methyl-4-prop-2-enoxyphenyl)methylidene]-1-(2-morpholin-4-ylethyl)pyrrolidine-2,3-dione</common-name> <description>(4e)-5-(3,4-dimethoxyphenyl)-4-[hydroxy-(3-methyl-4-prop-2-enoxyphenyl)methylidene]-1-(2-morpholin-4-ylethyl)pyrrolidine-2,3-dione is a chemical compound with the formula C29H34N2O7. With an average molecular weight of 522.60 g/mol, (4e)-5-(3,4-dimethoxyphenyl)-4-[hydroxy-(3-methyl-4-prop-2-enoxyphenyl)methylidene]-1-(2-morpholin-4-ylethyl)pyrrolidine-2,3-dione is a heavy molecule.</description> <cas>617696-10-3</cas> <pubchem-id>5942895</pubchem-id> <chemical-formula>C29H34N2O7</chemical-formula> <weight>522.6</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T14:21:06Z</created-at> <updated-at type="dateTime">2026-08-31T14:21:06Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=C(C=CC(=C1)C(=C2C(N(C(=O)C2=O)CCN3CCOCC3)C4=CC(=C(C=C4)OC)OC)O)OCC=C</moldb-smiles> <moldb-formula>C29H34N2O7</moldb-formula> <moldb-inchi>InChI=1S/C29H34N2O7/c1-5-14-38-22-8-7-21(17-19(22)2)27(32)25-26(20-6-9-23(35-3)24(18-20)36-4)31(29(34)28(25)33)11-10-30-12-15-37-16-13-30/h5-9,17-18,26,32H,1,10-16H2,2-4H3/b27-25+</moldb-inchi> <moldb-inchikey>XMKVKHQBPJHRAV-IMVLJIQESA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">522.2366014</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>3.5</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM345588</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(4e)-5-(3,4-dimethoxyphenyl)-4-[hydroxy-(3-methyl-4-prop-2-enoxyphenyl)methylidene]-1-(2-morpholin-4-ylethyl)pyrrolidine-2,3-dione</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Pyrrolidines</klass> <subklass>Phenylpyrrolidines</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0300018</sync-id> <structure-inchikey>XMKVKHQBPJHRAV-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>4000008002000000000008000000000000000000001000004000000400000000200000000000000000040000000000000000000100000000000010000000000002000200000000000000208000000003000000000000000000000000000100000000400000001100000000000211080200000000000010001000000000400000000000000000200040000080000000000000000004200000010000000000000000000002000841000400081000c008000008a000000004000090000000000000000000000000040000000000004000002800000200000100010010000000000040000040000000000000000000100020040000000800000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAAKQAAAIABBgBgAAAAAQMGQCgAAAAD BAZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEG ACgAAAADBAYAKAAAAAMEBgBgAAAAAwEHACgAAAADAwYAKAAAAAMECAAoAAAA AwIGACgAAAADBAgAKAAAAAMCBgBgAAAAAgIGAGAAAAACAgcAIAAAAAMGAGAA AAACAgYAYAAAAAICCAAgAAAAAgYAYAAAAAICBgBgAAAAAgIGQCgAAAADBAZA aAAAAAMDAQZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEIACgA AAADAgYAYAAAAAEDCAAoAAAAAwIGAGAAAAABAwgAaAAAAAMBAQgAKAAAAAMC BgBgAAAAAgIGAGgAAAADAwEGAGgAAAADAgILAAEAAQJoDAIDaAwDBGgMBAVo DAUGaAwFByAHCCgCCAkACQoACgsgCwwoAgsNIA0OKAIKDwAPEAAQEQAREgAS EwATFAAUFQAVFgAJFwAXGGgMGBloDBkaaAwaG2gMGxxoDBodIB0eABkfIB8g AAchIAIiICIjACMkACQlCAIGAWgMDQggFhEAHBdoDEIEAAAABgEGBQQDAgUL CgkIDQYSExQVFhEGGBkaGxwXFwQAAAAAAAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:47:45Z</structure-indexed-at> </compound>